Breaking News
Sort by:
Top Post
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
Evonetix Appoints Colin McCracken as Chief Executive Officer
EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced the […]
Hephaï Appoints Armelle Roussac as Head of Sales
Hephaï, a French start-up developing an AI-based digital education platform, today announces the appointment of […]
Metrion Biosciences Appoints Dr Benedetta Montagnini as Head of European Business Development
Metrion Biosciences Limited (“Metrion”), the specialist ion channel contract research and drug discovery company, today […]
Dotmatics Strengthens Leadership Team as it Continues to Invest in Organization Capabilities and Accelerate Growth
Dotmatics, the leader in R&D scientific software connecting science, data, and decision-making, today announced the […]
Tobias Hauser Joins Limbic to Help Close UK Demand-supply Gap of Psychological Therapy
Tobias Hauser, joins Limbic as its Head of Computational Psychiatry. Hauser has worked at the […]
Tetra Bio-Pharma Appoints Chief Financial Officer
Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1) a leader in cannabinoid-derived […]
GSK Announces Further Appointments to Designate Haleon Board
GSK plc (LSE/NYSE: GSK) has today announced the appointments of Asmita Dubey, Marie-Anne Aymerich and […]
RemedyBio Introduces Scientific Advisory Board
RemedyBio, a biotech company pioneering its proprietary ultra-high throughput single cell Nanoreactor™ platform for discovery […]
Arcellx Appoints Michelle Gilson as Chief Financial Officer
Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies […]
Thabor Therapeutics Appoints Jérémie Mariau as Ceo
Thabor Therapeutics, a company developing an innovative treatment for patients living with chronic mucosal inflammatory […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more